683 Capital Management, LLC Mereo Biopharma Group PLC Transaction History
683 Capital Management, LLC
- $1.17 Billion
- Q1 2024
A detailed history of 683 Capital Management, LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, 683 Capital Management, LLC holds 5,750,000 shares of MREO stock, worth $20.7 Million. This represents 1.62% of its overall portfolio holdings.
Number of Shares
5,750,000
Previous 6,200,000
7.26%
Holding current value
$20.7 Million
Previous $14.3 Million
32.49%
% of portfolio
1.62%
Previous 1.46%
Shares
6 transactions
Others Institutions Holding MREO
# of Institutions
88Shares Held
85.6MCall Options Held
182KPut Options Held
249K-
Rubric Capital Management LP New York, NY13.6MShares$48.8 Million1.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.33MShares$33.6 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.75MShares$31.5 Million3.09% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD8.14MShares$29.3 Million0.7% of portfolio
-
Janus Henderson Group PLC London, X05.12MShares$18.4 Million0.01% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $450M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...